Table of contents

Original articles

• The influence of extent of surgical margin positivity on prostate specific antigen recurrence (27 September, 2005)

  R E Emerson, M O Koch, T D Jones, J K Daggy, B E Juliar, L Cheng
• Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress (27 September, 2005)

  E Sivridis, A Giatromanolaki, M I Koukourakis
• KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype (27 September, 2005)

  A Carbone, A Gloghini, E Vaccher, G Marchetti, G Gaidano, U Tirelli
• Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma (27 September, 2005)

  F Farabegoli, C Ceccarelli, D Santini, M Taffurelli
• A practical approach to the clinical diagnosis of Ewing’s sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue (27 September, 2005)

  U Yamaguchi, T Hasegawa, Y Morimoto, U Tateishi, M Endo, F Nakatani, A Kawai, H Chuman, Y Beppu, M Endo, H Kurotaki, K Furuta
• Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn’s disease (27 September, 2005)

  D Kawashima, N Oshitani, Y Jinno, K Watanabe, S Nakamura, K Higuchi, T Arakawa
• H19 expression in hepatic metastases from a range of human carcinomas (27 September, 2005)

  Y Fellig, I Ariel, P Ohana, P Schachter, I Sinelnikov, T Birman, S Ayesh, T Schneider, N de Groot, A Czerniak, A Hochberg
• Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma (27 September, 2005)

  C Röcken, J Licht, A Roessner, S Carl-McGrath
• Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung (27 September, 2005)

  H Awaya, Y Takeshima, O Furonaka, N Kohno, K Inai
• Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas (27 September, 2005)

  J Gong, N Chen, Q Zhou, B Yang, Y Wang, X Wang
• IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest™ in breast carcinoma (27 September, 2005)

  R Ainsworth, J M S Bartlett, J J Going, E A Mallon, A Forsyth, J Richmond, W Angerson, A Watters, B Dunne
• STRAD in Peutz-Jeghers syndrome and sporadic cancers (27 September, 2005)

  W W J de Leng, J J Keller, S Luiten, A R Musler, M Jansen, A F Baas, F W M de Rooij, J J P Gille, F H Menko, G J A Offerhaus, M A J Weterman
• A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions (27 September, 2005)

  A G Bais, I Beckmann, J Lindemans, P C Ewing, C J L M Meijer, P J F Snijders, T J M Helmerhorst